Unequal center sizes, sample size, and power in multicenter clinical trials

Drug Information Journal

Volumn 38, Issue 4, 2004, Pages 387-394

  Etuvuna, Francis ^a,b  

^a Ilex Oncology Inc   (United States)

^b AAI Pharma Inc   (United States)

Author keywords

Center imbalance; Coefficient of imbalance; Effective sample size; Multicenter clinical trials; Power

Indexed keywords

CLINICAL RESEARCH; CLINICAL TRIAL; DATA ANALYSIS; HYPOTHESIS; MATERIAL STATE; MULTICENTER STUDY; POPULATION SIZE; PRIORITY JOURNAL; REVIEW; SAMPLING; STATISTICAL ANALYSIS; STATISTICAL MODEL; VALIDATION PROCESS;

EID: 8644246109     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Senn S. Statistical Issues in Drug Development: Multi-center Trials. New York: Wiley; 1997;187-206.
2. Senn S. Some controversies in planning and analyzing multi-center trials. Stat. Med. 1998;17:1753-1765.
3. Searle SR. Linear Models. New York: Wiley; 1971.
4. Searle SR, Speed FM, Milliken GA. Population marginal means in the linear model: An alternative to least squares means. Am Stat. 1980;34(4): 216-221.
5. Searle SR, Speed FM, Henderson HV. Some computational and model equivalences in analyses of variance of unequal-subclass-numbers data. Am Stat. 1981;35(1):16-33.
6. Jones B, Teather D, Wang J, Lewis JA. A comparison of various estimators of a treatment difference for a multi-centre clinical trial. Stat Med. 1998;17:1767-1777.
7. Center for Drug Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services. Guideline for the Format and Content of the Clinical and Statistical Sections of New Drug Applications. Rockville, MD: U.S. Food and Drug Administration; 1988:68-71.
8. Fleiss JL. The Design and Analysis of Clinical Experiments: Multicenter studies. New York: Wiley; 1985;176-185.
9. Fleiss JL. Analysis of data from multiclinic trials. Control Clin Trials. 1986;7:267-275.
10. Snedecor GW, Cochran WG. Statistical Methods. Iowa State University Press; 1973.
11. Lin Z. An issue of statistical analysis in controlled multi-centre studies: How shall we weight the centers? Stat Med. 1999;18:365-373.
12. Gallo PP. Practical issues in linear models analyses in multicenter clinical trials. Am Stat Assoc: Biopharm Report. 1998;4(2):2-9.
13. Jennings E, Ward JH, Jr. Hypothesis identification in the case of the missing cell. Am Stat. 982;36(1):25-27.
14. Ganju J, Mehrotra DV. Stratified experiments reexamined with emphasis on multicenter trials. Control Clin Trials. 2003;24:167-181.
15. Lin Z. The number of centers in a multicenter clinical study: Effects on statistical power. Drug Inf J. 2000;34:379-386.
16. Ahrens H, Pincus R. On two measures of unbalancedness in a one-way model and their relation to efficiency. Biom J. 1981;23(3):227-235.
17. Federer WT, Zelen M. Analysis of multifactor classifications with unequal numbers of observations. Biometrics. 1966;22:525-552.
18. Yates F. The analysis of multiple classification with unequal numbers in different classes. J Am Stat Assoc. 1934;29:51-66.
19. Harrell FE, Gallo PP. Covariable adjustment, multivariable modeling and validation strategies, and accounting for sites in randomized clinical trials. Proceedings: D/A Annual Workshop on Global Challenges and Strategies in the Pharmaceutical Industry. Horsham, PA: Drug Information Association; 1999; Chapter 5:68-111.
20. Gould AL. Multi-centre trial analysis revisted. Stat Med. 1998;17:1779-1797.